Cancer Research CTRC-AACR San Antonio Breast Cancer Symposium Tumor Immunology: New Perspectives
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Wistuba, I. I.
Right arrow Articles by Minna, J. D.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Wistuba, I. I.
Right arrow Articles by Minna, J. D.
[Cancer Research 60, 1949-1960, April 1, 2000]
© 2000 American Association for Cancer Research

Molecular Biology and Genetics

High Resolution Chromosome 3p Allelotyping of Human Lung Cancer and Preneoplastic/Preinvasive Bronchial Epithelium Reveals Multiple, Discontinuous Sites of 3p Allele Loss and Three Regions of Frequent Breakpoints1

Ignacio I. Wistuba, Carmen Behrens, Arvind K. Virmani, Gina Mele, Sara Milchgrub, Luc Girard, John W. Fondon, III, Harold R. Garner, Bruce McKay, Farida Latif, Michael I. Lerman, Stephen Lam, Adi F. Gazdar and John D. Minna2

Departments of Pathology [A. K. V., S. M., A. F. G.] and Internal Medicine and Pharmacology [J. D. M.], Hamon Center for Therapeutic Oncology Research [I. I. W., C. B., A. K. V., G. M., L. G., A. F. G., J. D. M.] and McDermott Center for Human Growth and Development and the Center for Biomedical Inventions, University of Texas Southwestern Medical Center [J. W. F., H. R. G.], Dallas, Texas 75390; Department of Pathology, Pontificia Universidad Catolica de Chile, Santiago, Chile [I. I. W.]; British Columbia Cancer Agency, Vancouver, British Columbia, V5Z 355 Canada [S. L.]; Department of Paediatrics and Child Health, University of Birmingham, Birmingham B15 2TT, United Kingdom [F. L.]; Laboratory of Immunobiology, National Cancer Institute-Frederick Cancer Research and Development Center, Frederick, Maryland 21702 [M. I. L.]; and Department of Pathology, The University of Texas M. D. Anderson Cancer Center, Houston, Texas 77030 [B. M.]

Allele loss involving chromosome arm 3p is one of the most frequent and earliest known genetic events in lung cancer pathogenesis and may affect several potential tumor suppressor gene regions. To further study the role of chromosome 3p allele loss in the pathogenesis of lung cancer, we performed high resolution loss of heterozygosity (LOH) studies on 97 lung cancer and 54 preneoplastic/preinvasive microdissected respiratory epithelial samples using a panel of 28 3p markers. Allelic losses of 3p were detected in 96% of the lung cancers and in 78% of the preneoplastic/preinvasive lesions. The allele losses were often multiple and discontinuous, with areas of LOH interspersed with areas of retention of heterozygosity. Most small cell lung carcinomas (91%) and squamous cell carcinomas (95%) demonstrated larger 3p segments of allele loss, whereas most (71%) of the adenocarcinomas and preneoplastic/preinvasive lesions had smaller chromosome areas of 3p allele loss. There was a progressive increase in the frequency and size of 3p allele loss regions with increasing severity of histopathological preneoplastic/preinvasive changes. In analyses of the specific parental allele lost comparing 42 preneoplastic/preinvasive foci with those lost in the lung cancer in the same patient (n = 10), the same parental allele was lost in 88% of 244 comparisons for 28 3p markers (P = 1.2 x 10-36 for this occurring by chance). This indicates the occurrence of allele-specific loss in these foci similar to that seen in the tumor by a currently unknown mechanism. Analysis of all of the data indicated multiple regions of localized 3p allele loss including telomere-D3S1597, D3S1111-D3S2432, D3S2432-D3S1537, D3S1537, D3S1537-D3S1612, D3S4604/Luca19.1-D3S4622/Luca4.1, D3S4624/Luca2.1, D3S4624/Luca2.1-D3S1582, D3S1766, D3S1234-D3S1300 (FHIT/FRA3B region centered on D3S1300), D3S1284-D3S1577 (U2020/DUTT1 region centered on D3S1274), and D3S1511-centromere. A panel of six markers in the 600-kb 3p21.3 deletion region showed loss in 77% of the lung cancers, 70% of normal or preneoplastic/preinvasive lesions associated with lung cancer, and 49% of 47 normal, mildly abnormal, or preneoplastic/preinvasive lesions found in smokers without lung cancer; however, loss was seen in 0% of 18 epithelial samples from seven never smokers. The 600-kb 3p21.3 region and the 3p14.2 (FHIT/FRA3B) and 3p12 (U2020/DUTT1) regions were common, independent sites of breakpoints (retention of heterozygosity by some markers and LOH by other markers in the immediate region). We conclude that 3p allele loss is nearly universal in lung cancer pathogenesis; involves multiple, discrete, 3p LOH sites that often show a "discontinuous LOH" pattern in individual tumors; occurs in preneoplastic/preinvasive lesions in smokers with and without lung cancer (multiple lesions often lose the same parental allele); frequently involves breakpoints in at least three very small defined genomic regions; and appears to have allele loss and breakpoints first occurring in the 600-kb 3p21.3 region. These findings are consistent with previously reported LOH studies in a variety of tumors showing allele loss occurring by mitotic recombination and induced by oxidative damage.




This article has been cited by other articles:


Home page
 Cancer Prevention ResearchHome page
X. Tang, M. Varella-Garcia, A. C. Xavier, E. Massarelli, N. Ozburn, C. Moran, and I. I. Wistuba
Epidermal Growth Factor Receptor Abnormalities in the Pathogenesis and Progression of Lung Adenocarcinomas
Cancer Prevention Research, August 1, 2008; 1(3): 192 - 200.
[Abstract] [Full Text] [PDF]

Home page
 Ann OncolHome page
G. J. Weiss, L. T. Bemis, E. Nakajima, M. Sugita, D. K. Birks, W. A. Robinson, M. Varella-Garcia, P. A. Bunn Jr, J. Haney, B. A. Helfrich, et al.
EGFR regulation by microRNA in lung cancer: correlation with clinical response and survival to gefitinib and EGFR expression in cell lines
Ann. Onc., June 1, 2008; 19(6): 1053 - 1059.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Respir. Crit. Care Med.Home page
M. Salaun, R. Sesboue, S. Moreno-Swirc, J. Metayer, S. Bota, J. Bourguignon, and L. Thiberville
Molecular Predictive Factors for Progression of High-Grade Preinvasive Bronchial Lesions
Am. J. Respir. Crit. Care Med., April 15, 2008; 177(8): 880 - 886.
[Abstract] [Full Text] [PDF]

Home page
 Clin. Cancer Res.Home page
S. Lam, B. Standish, C. Baldwin, A. McWilliams, J. leRiche, A. Gazdar, A. I. Vitkin, V. Yang, N. Ikeda, and C. MacAulay
In vivo Optical Coherence Tomography Imaging of Preinvasive Bronchial Lesions
Clin. Cancer Res., April 1, 2008; 14(7): 2006 - 2011.
[Abstract] [Full Text] [PDF]

Home page
 Clin. Cancer Res.Home page
L. Prudkin, C. Behrens, D. D. Liu, X. Zhou, N. C. Ozburn, B. N. Bekele, J. D. Minna, C. Moran, J. A. Roth, L. Ji, et al.
Loss and Reduction of Fus1 Protein Expression is a Frequent Phenomenon in the Pathogenesis of Lung Cancer
Clin. Cancer Res., January 1, 2008; 14(1): 41 - 47.
[Abstract] [Full Text] [PDF]

Home page
 Cancer Res.Home page
H. Wang, D. Teske, A. Tess, R. Kohlhepp, Y. Choi, C. Kendziorski, and A. R. Moser
Identification of Novel Modifier Loci of ApcMin Affecting Mammary Tumor Development
Cancer Res., December 1, 2007; 67(23): 11226 - 11233.
[Abstract] [Full Text] [PDF]

Home page
 CarcinogenesisHome page
P. G. Nuciforo, C. Luise, M. Capra, G. Pelosi, and F. d'Adda di Fagagna
Complex engagement of DNA damage response pathways in human cancer and in lung tumor progression
Carcinogenesis, October 1, 2007; 28(10): 2082 - 2088.
[Abstract] [Full Text] [PDF]

Home page
 Brief Funct Genomic ProteomicHome page
D. Angeloni
Molecular analysis of deletions in human chromosome 3p21 and the role of resident cancer genes in disease
Brief Funct Genomic Proteomic, May 24, 2007; (2007) elm007v1.
[Abstract] [Full Text] [PDF]

Home page
 Clin. Cancer Res.Home page
V. Donati, G. Fontanini, M. Dell'Omodarme, M. C. Prati, S. Nuti, M. Lucchi, A. Mussi, M. Fabbri, F. Basolo, C. M. Croce, et al.
WWOX Expression in Different Histologic Types and Subtypes of Non-Small Cell Lung Cancer
Clin. Cancer Res., February 1, 2007; 13(3): 884 - 891.
[Abstract] [Full Text] [PDF]

Home page
 Cancer Res.Home page
W.-G. Deng, H. Kawashima, G. Wu, G. Jayachandran, K. Xu, J. D. Minna, J. A. Roth, and L. Ji
Synergistic Tumor Suppression by Coexpression of FUS1 and p53 Is Associated with Down-regulation of Murine Double Minute-2 and Activation of the Apoptotic Protease-Activating Factor 1-Dependent Apoptotic Pathway in Human Non-Small Cell Lung Cancer Cells
Cancer Res., January 15, 2007; 67(2): 709 - 717.
[Abstract] [Full Text] [PDF]

Home page
 Clin. Cancer Res.Home page
R. Li, N. W. Todd, Q. Qiu, T. Fan, R. Y. Zhao, W. H. Rodgers, H.-B. Fang, R. L. Katz, S. A. Stass, and F. Jiang
Genetic Deletions in Sputum as Diagnostic Markers for Early Detection of Stage I Non-Small Cell Lung Cancer
Clin. Cancer Res., January 15, 2007; 13(2): 482 - 487.
[Abstract] [Full Text] [PDF]

Home page
 Cancer Epidemiol. Biomarkers Prev.Home page
N. Rehfeld, H. Geddert, A. Atamna, H. E. Gabbert, U. Steidl, R. Fenk, R. Kronenwett, R. Haas, and U.-P. Rohr
Coexpression of Fragile Histidine Triad and c-kit Is Relevant for Prediction of Survival in Patients with Small Cell Lung Cancer.
Cancer Epidemiol. Biomarkers Prev., November 1, 2006; 15(11): 2232 - 2238.
[Abstract] [Full Text] [PDF]

Home page
 Cancer Res.Home page
K. Ueda, H. Kawashima, S. Ohtani, W.-G. Deng, M. Ravoori, J. Bankson, B. Gao, L. Girard, J. D. Minna, J. A. Roth, et al.
The 3p21.3 Tumor Suppressor NPRL2 Plays an Important Role in Cisplatin-Induced Resistance in Human Non-Small-Cell Lung Cancer Cells
Cancer Res., October 1, 2006; 66(19): 9682 - 9690.
[Abstract] [Full Text] [PDF]

Home page
 Cancer Epidemiol. Biomarkers Prev.Home page
P. Bavi, Z. Jehan, V. Atizado, H. Al-Dossari, F. Al-Dayel, A. Tulbah, S. S. Amr, S. S. Sheikh, A. Ezzat, H. El-Solh, et al.
Prevalence of fragile histidine triad expression in tumors from saudi arabia: a tissue microarray analysis.
Cancer Epidemiol. Biomarkers Prev., September 1, 2006; 15(9): 1708 - 1718.
[Abstract] [Full Text] [PDF]

Home page
 Cancer Res.Home page
T. Rauch, H. Li, X. Wu, and G. P. Pfeifer
MIRA-Assisted Microarray Analysis, a New Technology for the Determination of DNA Methylation Patterns, Identifies Frequent Methylation of Homeodomain-Containing Genes in Lung Cancer Cells
Cancer Res., August 15, 2006; 66(16): 7939 - 7947.
[Abstract] [Full Text] [PDF]

Home page
 Cancer Res.Home page
S. Diederichs and D. A. Haber
Sequence Variations of MicroRNAs in Human Cancer: Alterations in Predicted Secondary Structure Do Not Affect Processing.
Cancer Res., June 15, 2006; 66(12): 6097 - 6104.
[Abstract] [Full Text] [PDF]

Home page
 Cancer Res.Home page
A. L.S. Tai, W. Mak, P. K.M. Ng, D. T.T. Chua, M. Y.M. Ng, L. Fu, K. K.W. Chu, Y. Fang, Y. Qiang Song, M. Chen, et al.
High-throughput Loss-of-Heterozygosity Study of Chromosome 3p in Lung Cancer Using Single-Nucleotide Polymorphism Markers.
Cancer Res., April 15, 2006; 66(8): 4133 - 4138.
[Abstract] [Full Text] [PDF]

Home page
 Cancer Res.Home page
F. D'Agostini, A. Izzotti, R. Balansky, N. Zanesi, C. M. Croce, and S. De Flora
Early loss of fhit in the respiratory tract of rodents exposed to environmental cigarette smoke.
Cancer Res., April 1, 2006; 66(7): 3936 - 3941.
[Abstract] [Full Text] [PDF]

Home page
 Clin. Cancer Res.Home page
Y. Tomizawa, H. Iijima, N. Sunaga, K. Sato, A. Takise, Y. Otani, S. Tanaka, T. Suga, R. Saito, T. Ishizuka, et al.
Clinicopathologic Significance of the Mutations of the Epidermal Growth Factor Receptor Gene in Patients with Non-Small Cell Lung Cancer
Clin. Cancer Res., October 1, 2005; 11(19): 6816 - 6822.
[Abstract] [Full Text] [PDF]

Home page
 Mol. Cell. Biol.Home page
L. van der Weyden, K. K. Tachibana, M. A. Gonzalez, D. J. Adams, B. L. Ng, R. Petty, A. R. Venkitaraman, M. J. Arends, and A. Bradley
The RASSF1A Isoform of RASSF1 Promotes Microtubule Stability and Suppresses Tumorigenesis
Mol. Cell. Biol., September 15, 2005; 25(18): 8356 - 8367.
[Abstract] [Full Text] [PDF]

Home page
 Cancer Res.Home page
X. Tang, H. Shigematsu, B. N. Bekele, J. A. Roth, J. D. Minna, W. K. Hong, A. F. Gazdar, and I. I. Wistuba
EGFR Tyrosine Kinase Domain Mutations Are Detected in Histologically Normal Respiratory Epithelium in Lung Cancer Patients
Cancer Res., September 1, 2005; 65(17): 7568 - 7572.
[Abstract] [Full Text] [PDF]

Home page
 Genes Dev.Home page
R. Meuwissen and A. Berns
Mouse models for human lung cancer
Genes & Dev., March 15, 2005; 19(6): 643 - 664.
[Abstract] [Full Text] [PDF]

Home page
 Cancer Res.Home page
H. Pan, J. Califano, J. F. Ponte, A. L. Russo, K.-h. Cheng, A. Thiagalingam, P. Nemani, D. Sidransky, and S. Thiagalingam
Loss of Heterozygosity Patterns Provide Fingerprints for Genetic Heterogeneity in Multistep Cancer Progression of Tobacco Smoke-Induced Non-Small Cell Lung Cancer
Cancer Res., March 1, 2005; 65(5): 1664 - 1669.
[Abstract] [Full Text] [PDF]

Home page
 Clin. Cancer Res.Home page
I. I. Wistuba
Histologic Evaluation of Bronchial Squamous Lesions: Any Role in Lung Cancer Risk Assessment?
Clin. Cancer Res., February 15, 2005; 11(4): 1358 - 1360.
[Full Text] [PDF]

Home page
 Clin. Cancer Res.Home page
U.-P. Rohr, N. Rehfeld, H. Geddert, L. Pflugfelder, I. Bruns, J. Neukirch, A. Rohrbeck, H. J. Grote, U. Steidl, R. Fenk, et al.
Prognostic Relevance of Fragile Histidine Triad Protein Expression in Patients with Small Cell Lung Cancer
Clin. Cancer Res., January 1, 2005; 11(1): 180 - 185.
[Abstract] [Full Text] [PDF]

Home page
 Cancer Res.Home page
C. J. Marsit, M. Hasegawa, T. Hirao, D.-H. Kim, K. Aldape, P. W. Hinds, J. K. Wiencke, H. H. Nelson, and K. T. Kelsey
Loss of Heterozygosity of Chromosome 3p21 Is Associated with Mutant TP53 and Better Patient Survival in Non-Small-Cell Lung Cancer
Cancer Res., December 1, 2004; 64(23): 8702 - 8707.
[Abstract] [Full Text] [PDF]

Home page
 CarcinogenesisHome page
J. S. Kim, H. Kim, Y. M. Shim, J. Han, J. Park, and D.-H. Kim
Aberrant methylation of the FHIT gene in chronic smokers with early stage squamous cell carcinoma of the lung
Carcinogenesis, November 1, 2004; 25(11): 2165 - 2171.
[Abstract] [Full Text] [PDF]

Home page
 Clin. Cancer Res.Home page
S. Lam, J. C. leRiche, A. McWilliams, C. MacAulay, Y. Dyachkova, E. Szabo, J. Mayo, R. Schellenberg, A. Coldman, E. Hawk, et al.
A Randomized Phase IIb Trial of Pulmicort Turbuhaler (Budesonide) in People with Dysplasia of the Bronchial Epithelium
Clin. Cancer Res., October 1, 2004; 10(19): 6502 - 6511.
[Abstract] [Full Text] [PDF]

Home page
 Cancer Res.Home page
J. Xian, A. Aitchison, L. Bobrow, G. Corbett, R. Pannell, T. Rabbitts, and P. Rabbitts
Targeted Disruption of the 3p12 Gene, Dutt1/Robo1, Predisposes Mice to Lung Adenocarcinomas and Lymphomas with Methylation of the Gene Promoter
Cancer Res., September 15, 2004; 64(18): 6432 - 6437.
[Abstract] [Full Text] [PDF]

Home page
 ChestHome page
P. J. Mazzone, T. Mekhail, and A. C. Arroliga
Is Lung Cancer in the Nonsmoker a Different Disease?
Chest, August 1, 2004; 126(2): 326 - 329.
[Full Text] [PDF]

Home page
 Eur Respir JHome page
D. Moro-Sibilot, F. Fievet, M. Jeanmart, S. Lantuejoul, F. Arbib, M.H. Laverriere, E. Brambilla, and C. Brambilla
Clinical prognostic indicators of high-grade pre-invasive bronchial lesions
Eur. Respir. J., July 1, 2004; 24(1): 24 - 29.
[Abstract] [Full Text] [PDF]

Home page
 Cancer Res.Home page
R. Pio, I. Zudaire, I. Pino, Z. Castano, N. Zabalegui, S. Vicent, F. Garcia-Amigot, M. D. Odero, M. D. Lozano, J. Garcia-Foncillas, et al.
{alpha}CP-4, Encoded by a Putative Tumor Suppressor Gene at 3p21, But Not Its Alternative Splice Variant {alpha}CP-4a, Is Underexpressed in Lung Cancer
Cancer Res., June 15, 2004; 64(12): 4171 - 4179.
[Abstract] [Full Text] [PDF]

Home page
 Cancer Res.Home page
F. Uno, J. Sasaki, M. Nishizaki, G. Carboni, K. Xu, E. N. Atkinson, M. Kondo, J. D. Minna, J. A. Roth, and L. Ji
Myristoylation of the Fus1 Protein Is Required for Tumor Suppression in Human Lung Cancer Cells
Cancer Res., May 1, 2004; 64(9): 2969 - 2976.
[Abstract] [Full Text] [PDF]

Home page
 ThoraxHome page
K M Fong, Y Sekido, A F Gazdar, and J D Minna
Lung cancer * 9: Molecular biology of lung cancer: clinical implications
Thorax, October 1, 2003; 58(10): 892 - 900.
[Abstract] [Full Text] [PDF]

Home page
 Proc. Natl. Acad. Sci. USAHome page
T. Ohira, R. M. Gemmill, K. Ferguson, S. Kusy, J. Roche, E. Brambilla, C. Zeng, A. Baron, L. Bemis, P. Erickson, et al.
WNT7a induces E-cadherin in lung cancer cells
PNAS, September 2, 2003; 100(18): 10429 - 10434.
[Abstract] [Full Text] [PDF]

Home page
 Cancer Res.Home page
A. Agathanggelou, I. Bieche, J. Ahmed-Choudhury, B. Nicke, R. Dammann, S. Baksh, B. Gao, J. D. Minna, J. Downward, E. R. Maher, et al.
Identification of Novel Gene Expression Targets for the Ras Association Domain Family 1 (RASSF1A) Tumor Suppressor Gene in Non-Small Cell Lung Cancer and Neuroblastoma
Cancer Res., September 1, 2003; 63(17): 5344 - 5351.
[Abstract] [Full Text] [PDF]

Home page
 Clin. Cancer Res.Home page
S. M. Dong, D.-I. Sun, N. E. Benoit, I. Kuzmin, M. I. Lerman, and D. Sidransky
Epigenetic Inactivation of RASSF1A in Head and Neck Cancer
Clin. Cancer Res., September 1, 2003; 9(10): 3635 - 3640.
[Abstract] [Full Text] [PDF]

Home page
 Cancer Res.Home page
D.-H. Kim, J. S. Kim, Y.-I. Ji, Y. M. Shim, H. Kim, J. Han, and J. Park
Hypermethylation of RASSF1A Promoter Is Associated with the Age at Starting Smoking and a Poor Prognosis in Primary Non-Small Cell Lung Cancer
Cancer Res., July 1, 2003; 63(13): 3743 - 3746.
[Abstract] [Full Text] [PDF]

Home page
 Cancer Res.Home page
T. Kuroki, F. Trapasso, S. Yendamuri, A. Matsuyama, H. Alder, N. N. Williams, L. R. Kaiser, and C. M. Croce
Allelic Loss on Chromosome 3p21.3 and Promoter Hypermethylation of Semaphorin 3B in Non-Small Cell Lung Cancer
Cancer Res., June 15, 2003; 63(12): 3352 - 3355.
[Abstract] [Full Text] [PDF]

Home page
 J. Virol.Home page
Y.-H. J. Chow, A. Alberti, M. Mura, C. Pretto, P. Murcia, L. M. Albritton, and M. Palmarini
Transformation of Rodent Fibroblasts by the Jaagsiekte Sheep Retrovirus Envelope Is Receptor Independent and Does Not Require the Surface Domain
J. Virol., June 1, 2003; 77(11): 6341 - 6350.
[Abstract] [Full Text] [PDF]

Home page
 Proc. Natl. Acad. Sci. USAHome page
M. Kost-Alimova, H. Kiss, L. Fedorova, Y. Yang, J. P. Dumanski, G. Klein, and S. Imreh
Coincidence of synteny breakpoints with malignancy-related deletions on human chromosome 3
PNAS, May 27, 2003; 100(11): 6622 - 6627.
[Abstract] [Full Text] [PDF]

Home page
 Cancer Res.Home page
I. Kuzmin, L. Liu, R. Dammann, L. Geil, E. J. Stanbridge, S. P. Wilczynski, M. I. Lerman, and G. P. Pfeifer
Inactivation of RAS Association Domain Family 1A Gene in Cervical Carcinomas and the Role of Human Papillomavirus Infection
Cancer Res., April 15, 2003; 63(8): 1888 - 1893.
[Abstract] [Full Text] [PDF]

Home page
 J. Cell Sci.Home page
A. Augustin, C. Spenlehauer, H. Dumond, J. Menissier-de Murcia, M. Piel, A.-C. Schmit, F. Apiou, J.-L. Vonesch, M. Kock, M. Bornens, et al.
PARP-3 localizes preferentially to the daughter centriole and interferes with the G1/S cell cycle progression
J. Cell Sci., April 15, 2003; 116(8): 1551 - 1562.
[Abstract] [Full Text] [PDF]

Home page
 BloodHome page
U. Novak, E. Oppliger Leibundgut, J. Hager, D. Muhlematter, M. Jotterand, C. Besse, N. Leupin, D. Ratschiller, J. Papp, G. Kearsey, et al.
A high-resolution allelotype of B-cell chronic lymphocytic leukemia (B-CLL)
Blood, August 13, 2002; 100(5): 1787 - 1794.
[Abstract] [Full Text] [PDF]

Home page
 Clin. Cancer Res.Home page
Y. Tomizawa, T. Kohno, H. Kondo, A. Otsuka, M. Nishioka, T. Niki, T. Yamada, A. Maeshima, K. Yoshimura, R. Saito, et al.
Clinicopathological Significance of Epigenetic Inactivation of RASSF1A at 3p21.3 in Stage I Lung Adenocarcinoma
Clin. Cancer Res., July 1, 2002; 8(7): 2362 - 2368.
[Abstract] [Full Text] [PDF]

Home page
 Mol. Cell. Biol.Home page
L. Shivakumar, J. Minna, T. Sakamaki, R. Pestell, and M. A. White
The RASSF1A Tumor Suppressor Blocks Cell Cycle Progression and Inhibits Cyclin D1 Accumulation
Mol. Cell. Biol., June 15, 2002; 22(12): 4309 - 4318.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Pathol.Home page
I. I. Wistuba, R. Ashfaq, A. Maitra, H. Alvarez, E. Riquelme, and A. F. Gazdar
Fragile Histidine Triad Gene Abnormalities in the Pathogenesis of Gallbladder Carcinoma
Am. J. Pathol., June 1, 2002; 160(6): 2073 - 2079.
[Abstract] [Full Text] [PDF]

Home page
 Cancer Res.Home page
L. Ji, M. Nishizaki, B. Gao, D. Burbee, M. Kondo, C. Kamibayashi, K. Xu, N. Yen, E. N. Atkinson, B. Fang, et al.
Expression of Several Genes in the Human Chromosome 3p21.3 Homozygous Deletion Region by an Adenovirus Vector Results in Tumor Suppressor Activities in Vitro and in Vivo
Cancer Res., May 1, 2002; 62(9): 2715 - 2720.
[Abstract] [Full Text] [PDF]

Home page
 Clin. Cancer Res.Home page
J. A. O'Shaughnessy, G. J. Kelloff, G. B. Gordon, A. J. Dannenberg, W. K. Hong, C. J. Fabian, C. C. Sigman, M. M. Bertagnolli, S. P. Stratton, S. Lam, et al.
Treatment and Prevention of Intraepithelial Neoplasia: An Important Target for Accelerated New Agent Development : Recommendations of the American Association for Cancer Research Task Force on the Treatment and Prevention of Intraepithelial Neoplasia
Clin. Cancer Res., February 1, 2002; 8(2): 314 - 346.
[Abstract] [Full Text] [PDF]

Home page
 Cancer Res.Home page
A. H. Banham, N. Beasley, E. Campo, P. L. Fernandez, C. Fidler, K. Gatter, M. Jones, D. Y. Mason, J. E. Prime, P. Trougouboff, et al.
The FOXP1 Winged Helix Transcription Factor Is a Novel Candidate Tumor Suppressor Gene on Chromosome 3p
Cancer Res., December 1, 2001; 61(24): 8820 - 8829.
[Abstract] [Full Text] [PDF]

Home page
 CarcinogenesisHome page
T. Tsujiuchi, Y. Sasaki, N. Murata, M. Tsutsumi, Y. Konishi, and D. Nakae
FHIT alterations in lung adenocarcinomas induced by N-nitrosobis(2-hydroxypropyl)amine in rats
Carcinogenesis, December 1, 2001; 22(12): 2017 - 2022.
[Abstract] [Full Text] [PDF]

Home page
 Proc. Natl. Acad. Sci. USAHome page
J. Xian, K. J. Clark, R. Fordham, R. Pannell, T. H. Rabbitts, and P. H. Rabbitts
Inadequate lung development and bronchial hyperplasia in mice with a targeted deletion in the Dutt1/Robo1 gene
PNAS, November 29, 2001; (2001) 251407098.
[Abstract] [Full Text] [PDF]

Home page
 Proc. Natl. Acad. Sci. USAHome page
Y. Tomizawa, Y. Sekido, M. Kondo, B. Gao, J. Yokota, J. Roche, H. Drabkin, M. I. Lerman, A. F. Gazdar, and J. D. Minna
Inhibition of lung cancer cell growth and induction of apoptosis after reexpression of 3p21.3 candidate tumor suppressor gene SEMA3B
PNAS, November 20, 2001; 98(24): 13954 - 13959.
[Abstract] [Full Text] [PDF]

Home page
 Cancer Res.Home page
Y. Aoyagi, T. Yokose, Y. Minami, A. Ochiai, T. Iijima, Y. Morishita, T. Oda, K. Fukao, and M. Noguchi
Accumulation of Losses of Heterozygosity and Multistep Carcinogenesis in Pulmonary Adenocarcinoma
Cancer Res., November 1, 2001; 61(21): 7950 - 7954.
[Abstract] [Full Text] [PDF]

Home page
 Mol. Pathol.Home page
A Martinez, R A Walker, J A Shaw, S J Dearing, E R Maher, and F Latif
Chromosome 3p allele loss in early invasive breast cancer: detailed mapping and association with clinicopathological features
Mol. Pathol., October 1, 2001; 54(5): 300 - 306.
[Abstract] [Full Text] [PDF]

Home page
 Cancer Res.Home page
D.-S. Byun, M.-G. Lee, K.-S. Chae, B.-G. Ryu, and S.-G. Chi
Frequent Epigenetic Inactivation of RASSF1A by Aberrant Promoter Hypermethylation in Human Gastric Adenocarcinoma
Cancer Res., October 1, 2001; 61(19): 7034 - 7038.
[Abstract] [Full Text] [PDF]